Home » Newsletters » BioWorld Asia

BioWorld Asia

April 11, 2001

View Archived Issues

Diversys Enters $10M Alliance, Secures $10M In Private Funding

MediGene Gains European Rights To Atrix's Leuprogel Product Line

DrugAbuse Completes $24M Financing To Advance Pipeline

Cardion Acquires Tolerance For Immunotherapy Platform

Merck Applies Crucell's Vector In Phase I HIV Vaccine Study

Ark Therapeutics' Gene Therapy Doubles Survival In Early Trial

ExonHit, Institut Curie Align In Cancer Pharmacogenomics

UK Parliament Seeks Moratorium On Insurers' Use Of Genetic Tests

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026